title: Telangiectasic mastocytosis with systemic sclerosis.
authors.forename: Makram
authors.initials: M
authors.lastname: Frigui
authors.forename: Nicolas
authors.initials: N
authors.lastname: Dupin
authors.forename: Agnès
authors.initials: A
authors.lastname: Carlotti
authors.forename: Guillaume
authors.initials: G
authors.lastname: Bussone
authors.forename: Vincent
authors.initials: V
authors.lastname: Pestre
authors.forename: Pierre
authors.initials: P
authors.lastname: Charles
authors.forename: Yoann
authors.initials: Y
authors.lastname: Crabol
authors.forename: Alice
authors.initials: A
authors.lastname: Bérezné
authors.forename: Loïc
authors.initials: L
authors.lastname: Guillevin
authors.forename: Luc
authors.initials: L
authors.lastname: Mouthon
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000097:blood; D005260:Female; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008407:Mast Cells / Q000648:ultrastructure; D034701:Mastocytosis, Cutaneous / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D008875:Middle Aged; D011537:Pruritus / Q000209:etiology; D011928:Raynaud Disease / Q000209:etiology; D045743:Scleroderma, Diffuse / Q000097:blood / Q000150:complications* / Q000175:diagnosis; D012867:Skin / Q000473:pathology; D013684:Telangiectasis / Q000209:etiology* / Q000473:pathology
chemical_list: D000974:Antibodies, Antinuclear; D006633:Histamine Antagonists